The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
Open accessAbstract
BACKGROUND: Funding for human papillomavirus (HPV) vaccination in Japan began in 2010 for girls aged 12-16 years, with three-dose coverage initially reaching more than 70%. On June 14, 2013, 2 months after formal inclusion in Japan's national immunisation programme, proactive recommendations for the HPV vaccine were suspended following reports of adverse events since found to be unrelated to vaccination, but which were extensively covered in the media. Vaccine coverage subsequently dropped to less than 1% and has remained this low to date. We aimed to quantify the impact of this vaccine hesitancy crisis, and the potential health gains if coverage can be restored. METHODS: In this modelling study, we used the Policy1-Cervix modelling platform. We adapted the model for Japan with use of data on HPV prevalence, screening practices and coverage, and cervical cancer incidence and mortality. We evaluated the expected number of cervical cancer cases and deaths over the lifetime of cohorts born from 1994 to 2007 in the context of the vaccine hesitancy crisis. We assessed a range of recovery scenarios from 2020 onwards, including a scenario in which routine coverage is restored to 70%, with 50% catch-up coverage for the missed cohorts (aged 13-20 years in 2020). To estimate the impact of the vaccine crisis to date, we also modelled a counterfactual scenario in which 70% coverage had been maintained in 12-year-olds from 2013 onwards. FINDINGS: The vaccine crisis from 2013 to 2019 is predicted to result in an additional 24 600-27 300 cases and 5000-5700 deaths over the lifetime of cohorts born between 1994 and 2007, compared with if coverage had remained at around 70% since 2013. However, restoration of coverage in 2020, including catch-up vaccination for missed cohorts, could prevent 14 800-16 200 of these cases and 3000-3400 of these deaths. If coverage is not restored in 2020, an additional 3400-3800 cases and 700-800 deaths will occur over the lifetime of individuals who are 12 years old in 2020 alone. If the crisis continues, 9300-10 800 preventable deaths due to cervical cancer will occur in the next 50 years (2020-69). INTERPRETATION: The HPV vaccine crisis to date is estimated to result in around 5000 deaths from cervical cancer in Japan. Many of these deaths could still be prevented if vaccination coverage with extended catch-up can be rapidly restored. FUNDING: National Health and Medical Research Council Australia Centre of Research Excellence in Cervical Cancer Control, Japan Society for the Promotion of Science.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
Chapter 1: HPV in the etiology of human cancer
Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.115 · Cited by 1,355
Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., Martin, D., Simms, K. T., Bénard, É., Boily, M.-C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30068-4 · Cited by 1,138
Self-citationMercer, C. H., Tanton, C., Prah, P., Erens, B., Sonnenberg, P., Clifton, S., Macdowall, W., Lewis, R., Field, N., Datta, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62035-8 · Cited by 724
Simms, K. T., Steinberg, J., Caruana, M., Smith, M. A., Lew, J.-B., Soerjomataram, I., Castle, P. E., Bray, F., & Canfell, K. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30836-2 · Cited by 486
Self-citationBrisson, M., Bénard, É., Drolet, M., Bogaards, J. A., Baussano, I., Vänskä, S., Jit, M., Boily, M.-C., Smith, M. A., Berkhof, J., et al. (2016) · The Lancet Public Health · doi:10.1016/s2468-2667(16)30001-9 · Cited by 307
Self-citationPotential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Serrano, B., Alemany, L., Tous, S., Bruni, L., Clifford, G. M., Weiss, T., Bosch, F. X., & de Sanjosé, S. (2012) · Infectious Agents and Cancer · doi:10.1186/1750-9378-7-38 · Cited by 301
Lew, J.-B., Simms, K. T., Smith, M. A., Hall, M., Kang, Y.-J., Xu, X. M., Caruana, M., Velentzis, L. S., Bessell, T., Saville, M., et al. (2017) · The Lancet Public Health · doi:10.1016/s2468-2667(17)30007-5 · Cited by 160
Self-citationCanfell, K., Kim, J. J., Kulasingam, S., Berkhof, J., Barnabas, R., Bogaards, J. A., Campos, N., Jennett, C., Sharma, M., Simms, K. T., et al. (2019) · Papillomavirus Research · doi:10.1016/j.pvr.2019.100184 · Cited by 68
Self-citation
Cited by
de Figueiredo, A., Simas, C., Karafillakis, E., Paterson, P., & Larson, H. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31558-0 · Cited by 1,143
Larson, H. J., Gakidou, E., & Murray, C. J. L. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2106441 · Cited by 510
Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic
Machida, M., Nakamura, I., Kojima, T., Saito, R., Nakaya, T., Hanibuchi, T., Takamiya, T., Odagiri, Y., Fukushima, N., Kikuchi, H., et al. (2021) · Vaccines · doi:10.3390/vaccines9030210 · Cited by 281
Simms, K. T., Keane, A., Nguyen, D. T. N., Caruana, M., Hall, M. T., Lui, G., Gauvreau, C., Demke, O., Arbyn, M., Basu, P., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02600-4 · Cited by 105
“It was previously extensively validated and used to evaluate changes to the screening interval in Australia and the United Kingdom 17,46 , the role of alternative technologies for screening in Australia, New Zealand and England 17,47–49 , the role of HPV testing for the follow-up management of women treated for cervic…”
Self-citationMachida, M., Inoue, S., Furuse, Y., Oka, E., Ueda, Y., Fukushima, S., & Tabuchi, T. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127434 · Cited by 6
Metadata
- Authors
- Simms, K. T., Hanley, S. J. B., Smith, M. A., Keane, A., & Canfell, K.
- Venue
- The Lancet Public Health
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 5
- Issue
- 4
- Pages
- e223-e234
- ISSN
- 2468-2667 (ISSN-L)
- OpenAlex
- W3004592448
- Cited by
- 223
- References
- 9
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. https://app.cochat.ai/papers/10.1016/s2468-2667(20)30010-4
- The paper
- Simms, K. T., Hanley, S. J. B., Smith, M. A., Keane, A., & Canfell, K. (2020). Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. The Lancet Public Health. https://doi.org/10.1016/s2468-2667(20)30010-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.